DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sharda Cropchem Limited — Board Meeting Intimation

NSE 1 hr ago·22 Oct 2026, 8:04 am

Sharda Cropchem

Sharda Cropchem Limited has announced that its board will meet on October 30, 2026, to review and approve the company's unaudited financial results for the half-year ending September 2026.

This update is a routine corporate procedure that provides investors with an early look at the company's financial health and operational performance for the first nine months of the fiscal year.

Investors should monitor this announcement for insights into the company's earnings trajectory and business momentum as it heads into the crucial festive season.